Peripheral GALR2 activation by the metabolically stabilized spexin analog LIT-01-144 produces potent opioid‑independent antinociception.
LIT-01-144 is designed and characterized, a modified spexin analog incorporating N-terminal fluorocarbon functionalization to improve metabolic stability while preserving receptor selectivity, and demonstrated the potential of LIT-01-144 as a valuable tool for understanding GALR2-mediated mechanisms of pain modulation.